and Zihe Rao a * a S100P, a Ca 2+ -binding protein, is a member of the S100 family. Its presence is associated with the development of prostate cancer, but its cellular function is not known. Recombinant human S100P has been expressed and puri®ed in bacterial cells and crystals of human S100P in the calcium-bound state have been grown using the vapourdiffusion technique with PEG 4000 as precipitant. Diffraction data have been obtained to a resolution of 2.0 A Ê from a single frozen S100P crystal which belongs to the space group P4 1 2 1 2, with unit-cell parameters a = b = 60.8, c = 47.6 A Ê .
Introduction
Calcium is responsible for the control of vital biochemical pathways. These Ca 2+ -dependent signal transduction pathways are achieved through the interaction of calcium ions with Ca 2+ -binding proteins (CaBPs). A large class of CaBPs share a common Ca 2+ -binding structural motif, the EF-hand (Kretsinger, 1976; Kawasaki & Kretsinger, 1995) . The S100 family is possibly the largest multigenic family and its proteins are characterized by a low molecular weight (Schafer & Heizmann, 1996) among the EF-hand proteins characterized by calcium binding. Owing to their relative abundance, the S100 proteins are thought to be involved in a variety of intracellular activities in a Ca 2+ -dependent (and in some cases Zn 2+ -, Cu 2+ -or Mg 2+ -dependent) manner, including protein phosphorylation, enzyme activities, cell proliferation (including neoplastic transformation) and differentiation, the dynamics of cytoskeleton constituents, intracellular Ca 2+ homeostasis and in¯ammation, modulation of cell proliferation or regulation of macrophage activation (Donato, 1999) . Another characteristic feature of S100 proteins is their cell-typespeci®c expression and their association with both neurological and neoplastic human diseases (Hilt & Kligman, 1991; Schafer & Heizmann, 1996) . Expression and an altered cellular localization of S100P are related to the development of prostate cancer (Averboukh et al., 1996) . Thus, for the S100 proteins, different cell-type-speci®c expression patterns may indicate their different functional roles.
Detailed studies of S100 proteins have revealed some important structural properties. S100 proteins are thought to function as Ca 2+ -sensor proteins that, with a few exceptions, undergo Ca 2+ -dependent conformational changes resulting in the exposure of a binding surface (Donato, 1999) . Commonly, they interact with their target proteins as homodimers or/and heterodimers such as (S100A1) 2 , (S100B) 2 , (S100A6) 2 and S100A/S100B under non-reducing conditions or even reducing conditions (Teigelkamp et al., 1991; Potts et al., 1995; Drohat et al., 1996; Kilby et al., 1996; Matsumura et al., 1998; Brodersen et al., 1998) . Thus, the members of the S100 protein family have some similar structural properties in common, but their speci®c roles and their localization in cells are likely to re¯ect subtle and possibly unique structure features associated with their interaction with particular target proteins.
Human S100P, a 95-residue protein, was ®rst isolated from human placenta (Becker et al., 1992; Emoto et al., 1992) and may be the least known member of the S100 family. Studies of the structure of S100P at low resolution show that S100P undergoes a signi®cant rearrangement of its tertiary structure with changes in Ca 2+ concentration and that the oligomer± dimer equilibrium of the S100P molecule moves towards oligomer upon the addition of Ca 2+ ions (Gribenko & Makhatadze, 1998) . Few details of S100P are known. The elucidation of the cellular functions and biochemical properties of S100P requires detailed structure information. Here, we report (i) a detailed protocol of protein preparation for crystallization, (ii) successful crystallization procedures and (iii) X-ray diffraction studies of S100P protein.
Experimental 2.1. Expression and purification
Production of recombinant human S100P from Escherichia coli strain BL21 was induced when the culture had grown to an optical density of OD 595 = 0.6±0.8 by the addition of 1 mM isopropyl--d-thiogalactopyranoside and the culture was grown for a further 2 h at 310 K. Cells harvested by centrifugation were suspended in 25 mM Tris±HCl pH 7.6, 50 mM NaCl and lysed by sonication. The supernatant obtained by centrifugation of the extract at 15 000 rev min À1 for 30 min was loaded onto a DEAE-Sepharose Fast Flow anion-exchange chromatography column (APB, Milton Keynes, England) equilibrated with 25 mM Tris±HCl pH 7.6, 50 mM NaCl. After washing out unbound protein with two bed volumes of buffer, a linear gradient of 0.05±0.6 M NaCl in the same buffer was applied. S100P was eluted at approximately 0.25 M NaCl. The collected fractions were brought to 2 mM with respect to CaCl 2 and centrifuged for 30 min at 15 000 rev min À1 . The supernatant was absorbed onto a phenyl-Sepharose column (APB) equilibrated with 25 mM Tris±HCl pH 7.6. Bound proteins were eluted with the same buffer containing 10 mM EGTA. The eluted fractions were concentrated and then subjected to HPLC/gel ®ltration on a Superdex G75 column with 120 ml column volume equilibrated and eluted with 5 mM Tris±HCl pH 8.0 containing 50 mM NaCl, 0.5 mM CaCl 2 . The collected protein sample was then concentrated for crystallization. After puri®cation according to the above steps, the purity of S100P is suitable for crystallization as determined by nonreducing 16.5% SDS±PAGE analysis (Fig. 1). 
Crystallization and X-ray diffraction analysis
Recombinant S100P was puri®ed from 1 l E. coli cell extracts as described above and concentrated to about 50 mg ml À1 in a solution containing 5 mM Tris±HCl pH 8.0, 50 mM NaCl and 0.5 mM CaCl 2 . Crystallization experiments were performed at 291 K using the hanging-drop vapourdiffusion method. Crystals appeared in 2 d when 1.2 ml of S100P protein in buffer was mixed with 1.2 ml reservoir solution (30±34% PEG 4000, 0.1 M sodium citrate pH 6.5) and equilibrated against 0.3 ml reservoir solution (Fig. 2) .
The preliminary X-ray diffraction analysis of the S100P crystal was performed at 110 K on an in-house MAR 345 image plate with a Rigaku rotatinganode Cu K X-ray generator operating at 48 kV and 98 mA (! = 1.5418 A Ê ). The space group has been determined to be P4 1 2 1 2, with unitcell parameters a = b = 60.8, c = 47.6 A Ê . X-ray diffraction data were collected to 2.0 A Ê resolution. All diffraction data were processed using the programs DENZO and SCALEPACK (Otwinowski & Minor, 1997) . The ®nal structure determination is in progress.
Results and discussion

Protein purification and crystal growth
After puri®cation by DEAE-Sepharose Fast Flow, phenyl-Sepharose and Sephadex G75 chromatography, one 10.4 kDa band corresponding to the molecular weight of S100P was visible on non-reducing 16.5% SDS±PAGE analysis. The weak band should correspond to the S100P dimer. On running reducing SDS±PAGE, the weak band disappears (Fig. 1) .
In order to determine the preliminary crystallization conditions, we employed screening crystallization kits (Hampton Research) using different protein concentrations and obtained crystals from some conditions containing ammonium salts. However, these crystals diffracted X-rays as salt crystals. At the same time, some other conditions produced multiple crystals. Further re®nements were carried out with no useful results. We continued to screen our home PEG kit. A full range of PEG 4000 and pH 6.0±8.5 was used for different crystallization trials. Some needle-shaped crystals were produced in buffers containing 22±28% PEG 4000, 0.1 M Tris±HCl pH 7.0 and 7.5, and 22±37% PEG 4000, 0.1 M sodium citrate pH 6.5; larger crystals appear in buffer containing 22±28% PEG 4000, 0.1 M Tris±HCl pH 8.0 and 8.5 when the protein concentration was below about 40 mg ml À1 , but they diffracted weakly with a resolution below 7 A Ê . Based on the preliminary results, several further rounds of re®nement were carried out, including altering the concentration of protein and precipitant and adding additives in the pH range 6.5±8.5. The crystal from buffer consisting of 20±40% PEG 4000 pH 7.0 and 7.5, 50±100 mg ml À1 protein diffracted to a resolution below 3.5 A Ê . This result shows no apparent improvement from buffer at pH 8.0 and 8.5. The crystals still diffracted weakly or as multiple crystals even though the crystals appeared to be good quality. The crystal diffracted to 2.0 A Ê when protein concentration was increased to 50 mg ml À1 or above and PEG 4000 concentration was increased to 30±34% at pH 6.5. In conclusion, we think that it is crucial to increase the concentration of protein and precipitant simultaneously at low pH for successful crystallization and to obtain a high-quality crystal. Purity determination of S100P by non-reducing 16.5% SDS±PAGE. Lanes 1±7, fractions after Superdex 75 (120 ml column volume); lane 8, protein concentrated for crystallization.
Figure 2
Crystals of human S100P. Crystals from buffer containing 30% PEG 4000, 0.1 M sodium citrate pH 5.0.
Figure 3
Typical diffraction pattern of a crystal of S100P. crystallization papers 3.2. Data collection and analysis X-ray diffraction data were collected to 2.0 A Ê resolution at 110 K in-house without additional cryoprotectant (Fig. 3) . The crystal-to-detector distance was 117 mm. The data were collected with 1.5 per frame over a 120 oscillation range. The crystal belongs to space group P4 1 2 1 2, with unit-cell parameters a = b = 60.8, c = 47.6 A Ê . There is one S100P molecule in an asymmetric unit. The Matthews coef®cient is 2.12 A Ê 3 Da À1 and the solvent content is about 40% (Matthews, 1968) . The X-ray data statistics are summarized in Table 1 . The ®nal structure determination is in progress. 
